Endometrial Cancer in the Hereditary Nonpolyposis Colorectal Cancer Syndrome

[1]  R. Kurman,et al.  A Binary Architectural Grading System for Uterine Endometrial Endometrioid Carcinoma Has Superior Reproducibility Compared With FIGO Grading and Identifies Subsets of Advance-Stage Tumors With Favorable and Unfavorable Prognosis , 2000, The American journal of surgical pathology.

[2]  M. Sherman,et al.  Minimal uterine serous carcinoma: diagnosis and clinicopathologic correlation. , 2000, The American journal of surgical pathology.

[3]  R. Slebos,et al.  The frequency of p53, k‐ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma , 2000, Cancer.

[4]  J. Herman,et al.  hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis. , 1999, The American journal of pathology.

[5]  K. Theil,et al.  HER-2/neu amplification and overexpression in endometrial carcinoma. , 1999, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[6]  Manel Esteller,et al.  MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas , 1998, Oncogene.

[7]  J. P. Geisler,et al.  Lack of bcl-2 persistence: an independent prognostic indicator of poor prognosis in endometrial carcinoma. , 1998, Gynecologic oncology.

[8]  R. Bentley,et al.  Villoglandular adenocarcinoma of the endometrium: a clinicopathologic study of 61 cases: a gynecologic oncology group study. , 1998, The American journal of surgical pathology.

[9]  S. Hirohashi,et al.  Beta-catenin mutation in carcinoma of the uterine endometrium. , 1998, Cancer research.

[10]  R. Levine,et al.  PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma. , 1998, Cancer research.

[11]  M. Sherman,et al.  Evidence for a common etiology for endometrial carcinomas and malignant mixed mullerian tumors. , 1998, Gynecologic oncology.

[12]  H. Watari,et al.  Bcl‐2 expression and prognosis of patients with endometrial carcinoma , 1998, International journal of cancer.

[13]  A. Berchuck,et al.  PTEN/MMAC1 mutations in endometrial cancers. , 1997, Cancer research.

[14]  M. Sherman,et al.  Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[15]  B. Iacopetta,et al.  Overexpression of p53 protein is an independent prognostic indicator in human endometrial carcinoma. , 1996, British Journal of Cancer.

[16]  E. Genega,et al.  Papillary carcinoma of the endometrium: morphometric predictors of survival. , 1996, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[17]  R. Kurman,et al.  Pathologic models to predict outcome for women with endometrial adenocarcinoma: The importance of the distinction between surgical stage and clinical stage‐‐A gynecologic oncology group study , 1996, Cancer.

[18]  M. Sherman,et al.  Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation. , 1995, Human pathology.

[19]  W. R. Hart,et al.  Carcinosarcomas of the female genital tract. A pathologic study of 29 metastatic tumors: further evidence for the dominant role of the epithelial component and the conversion theory of histogenesis. , 1995, The American journal of surgical pathology.

[20]  C. Dunton,et al.  Endometrial hyperplasia and the risk of carcinoma , 1994, International Journal of Gynecologic Cancer.

[21]  M. Janicek,et al.  Invasive endometrial cancer in uteri resected for atypical endometrial hyperplasia. , 1994, Gynecologic oncology.

[22]  B. Corn,et al.  Pathologic stage III endometrial carcinoma. Prognostic factors and patterns of recurrence , 1993, Cancer.

[23]  M. Inoue,et al.  Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium. , 1993, Cancer research.

[24]  J. Baak,et al.  The effect of chemotherapy on the different components of advanced carcinosarcomas (malignant mixed mesodermal tumors) of the female genital tract , 1993, International Journal of Gynecologic Cancer.

[25]  M. Carcangiu,et al.  Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma. , 1992, Gynecologic oncology.

[26]  J. Baak,et al.  Assessment of the risk on endometrial cancer in hyperplasia, by means of morphological and morphometrical features. , 1992, Pathology, research and practice.

[27]  T. Burke,et al.  Aggressive stage I grade 1 endometrial carcinoma , 1992, Cancer.

[28]  M. Sherman,et al.  Uterine Serous Carcinoma A Morphologically Diverse Neoplasm With Unifying Clinicopathologic Features , 1992, The American journal of surgical pathology.

[29]  R. Kurman,et al.  Combined assessment of vascular and myometrial invasion as a model to predict prognosis in stage I endometrioid adenocarcinoma of the uterine corpus , 1992, Cancer.

[30]  D. Herbold,et al.  The significance of squamous differentiation in endometrial carcinoma. Data from a gynecologic oncology group study , 1991, Cancer.

[31]  V. Abeler,et al.  Carcinoma of the endometrium in Norway: a histopathological and prognostic survey of a total population , 1991, International Journal of Gynecologic Cancer.

[32]  J. Nesland,et al.  Undifferentiated carcinoma of the endometrium. A histopathologic and clinical study of 31 cases , 1991, Cancer.

[33]  V. Abeler,et al.  Clear cell carcinoma of the endometrium: a histopathological and clinical study of 97 cases. , 1990, Gynecologic oncology.

[34]  R. Kurman,et al.  Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group study , 1991 .

[35]  R. Scully,et al.  Peritoneal Keratin Granulomas with Carcinomas of Endometrium and Ovary and Atypical Polypoid Adenomyoma of Endometrium A Clinicopathological Analysis of 22 Cases , 1990, The American journal of surgical pathology.

[36]  M. Tompkins,et al.  Prognostic value of peritoneal cytology in endometrial carcinoma , 1990, Gynecologic oncology.

[37]  R. Kurman,et al.  The Significance of Epithelial Differences in Mixed Mesodermal Tumors of the Uterus: A Clinicopathologic and Immunohistochemical Study , 1990, The American journal of surgical pathology.

[38]  R. Slavin,et al.  Mixed Mullerian Tumors of the Uterus: A Clinicopathologic Study , 1989, Obstetrics and gynecology.

[39]  A. Ferenczy,et al.  The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasia. , 1989 .

[40]  R. Kurman,et al.  Squamous differentiation in carcinoma of the endometrium: a critical appraisal of adenoacanthoma and adenosquamous carcinoma. , 1988, Seminars in diagnostic pathology.

[41]  H. Fox,et al.  The prognostic significance of lymphatic vascular space invasion in endometrial adenocarcinoma , 1987, British journal of obstetrics and gynaecology.

[42]  R. Kurman,et al.  The behavior of endometrial hyperplasia. A long‐term study of “untreated” hyperplasia in 170 patients , 1985 .

[43]  R. Wagner,et al.  Stromal invasion in endometrial adenocarcinoma. , 1984, American journal of obstetrics and gynecology.

[44]  R. Iozzo.  Proteoglycans and neoplastic--mesenchymal cell interactions. , 1984, Human pathology.

[45]  R. Kurman,et al.  Endometrial hyperplasia and carcinoma. Diagnostic considerations. , 1983, The American journal of surgical pathology.

[46]  R. Kempson,et al.  Primary mucinous adenocarcinoma of the endometrium: A clinicopathologic and histochemical study* , 1983, The American journal of surgical pathology.

[47]  J. V. Bokhman.  Two pathogenetic types of endometrial carcinoma. , 1983, Gynecologic oncology.

[48]  L. Liotta,et al.  Tumor invasion and the extracellular matrix. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[49]  R. Kurman,et al.  Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well‐differentiated carcinoma , 1982 .

[50]  R. Kempson,et al.  Uterine papillary serous carcinoma: A highly malignant form of endometrial adenocarcinoma , 1982, The American journal of surgical pathology.

[51]  Tiltman Aj.  Mucinous carcinoma of the endometrium. , 1980 .

[52]  V. Livolsi,et al.  Malignant mixed müllerian tumors of the uterus: A clinicopathologic assessment of 34 cases , 1979, The American journal of surgical pathology.

[53]  F. Tavassoli,et al.  Endometrial lesions in uteri resected for atypical endometrial hyperplasia. , 1978, American journal of clinical pathology.

[54]  S. B. Gusberg.  THE TEACHING HOSPITAL EXPERIENCE. , 1963, American journal of obstetrics and gynecology.